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Incidence of infectious complications in 
hip and knee arthroplasties in rheumatoid 
arthritis and osteoarthritis patients
Bernardo Matos da Cunha1, Sandro Barbosa de Oliveira2, Leopoldo Santos-Neto3
ABSTRACT
Introduction: Rheumatoid arthritis (RA) is one of the major indications of total hip (THA) or knee (TKA) arthroplasty. 
International studies have suggested that RA is a risk factor for prosthesis infections. Objectives: To compare patients 
with RA and patients with osteoarthritis (OA) of other etiologies with regard to the incidence of prosthesis, incisional, 
and other systemic postoperative infections in THA and TKA. Methods: Retrospective, comparative cohort of patients 
followed up after undergoing THA or TKA at the Hospital SARAH-Brasília, from 1996 to 2007. Results: Seventy-fi ve 
arthroplasties (28 TKA and 47 THA) were identifi ed in RA patients. As controls, 131 surgeries (56 TKA and 75 THA) 
in OA patients were randomly selected and stratifi ed by surgery and gender. No signifi cant difference was observed 
between the RA and OA groups regarding the rates of prosthesis infections (TKA 7.1% vs. 0% and THA 2.1% vs. 0%, 
respectively, both with P > 0.1), incisional infections (TKA 14.3% vs. 3.3% and THA 4.3 vs. 1.3%, respectively, both 
with P > 0.1), and systemic infections (TKA 7.1% vs. 3.6%, P = 0.92 and THA 4.3% vs. 10.7%, P > 0.1, respectively). 
After multiple logistic regression, the results did not change. Conclusions: RA was not identifi ed as a risk factor for 
perioperative infections in THA and TKA in this case series of the Hospital SARAH-Brasília, as compared with the 
group of patients with primary OA or OA secondary to non-infl ammatory diseases. The low incidence of infections in 
both groups may explain our fi ndings. 
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INTRODUCTION
Rheumatoid arthritis (RA) affects 0.2% to 1% of the Brazilian 
population.1 Its main characteristic is peripheral, symmetric 
polyarthritis, which leads to joint deformity and destruction 
by erosion of both bone and cartilage. Many patients progress 
to secondary osteoarthritis (OA), which, together with OA and 
traumatic lesions, represents one of the most frequent indica-
tions of total arthroplasty. 
Patients affected by RA have a different profi le from those 
with OA due to other etiologies. Osteoarthritis usually affects 
patients over the age of 50 years, while RA may affect younger 
patients.2 Furthermore, they have chronic systemic infl amma-
tion, usually use immunomodulatory drugs and corticosteroids, 
and more often have other comorbidities, such as osteoporosis,3 
other autoimmune diseases,4 and early atherosclerosis.5 Such 
patients may be more susceptible to complications, such as 
surgical infections, suture dehiscence, periprosthetic fractures, 
and shorter prosthesis durability, which have a great impact on 
morbidity, mortality, and quality of life.
The fi rst comparative studies have not evidenced shorter 
prosthesis durability in RA patients,6,7 while others have shown 
that such patients have important benefi ts regarding pain and 
joint function with surgical treatment.8,9 However, two stud-
ies, including a recently-published retrospective cohort, have 
evidenced a small increase in the number of revisions due to 
infection in RA patients.10,11 Case-control studies conducted 
with a large number of patients undergoing arthroplasties have 
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pointed out RA12–17 and the use of corticosteroids18 as risk fac-
tors for infections.
The objective of this study is to compare patients with RA 
and OA due to other etiologies with regard to the incidence 
of prosthesis infections, incisional infection and other postop-
erative systemic infections in total hip (THA) and total knee 
(TKA) arthroplasties. 
MATERIALS AND METHODS 
Study design
Retrospective, comparative study of patients with RA and OA 
due to other etiologies, undergoing THA and TKA.
Inclusion and exclusion criteria
The participants of the study were 18 years old or older. The 
study included patients followed up at the orthopedics program 
after undergoing THA or TKA, with the fi rst joint arthroplasty 
performed at the Hospital SARAH-Brasília, from 1996 to 2007. 
The group of RA patients had their diagnosis established 
based on the 1987 American College of Rheumatology (ACR) 
criteria.19 The control-group comprised patients with primary 
OA or OA secondary to other etiologies, whose diagnosis was 
established based on the ACR clinical-radiographic criteria,20–22 
by using clinical, laboratory and radiological data, whose dates 
were as close as possible to that of the surgery. If possible, two 
OA patients for each RA patient would be included, randomly 
selected within the universe of patients undergoing surgery 
within the same period, even if they had already undergone 
other previous joint surgeries different from arthroplasty 
(e.g., osteotomy). The sample was balanced by gender and 
operated-upon joint. 
The following patients were excluded from the study:  RA 
patients with indication for arthroplasty due to avascular bone 
necrosis or femoral neck fracture; patients with OA secondary 
to other autoimmune diseases, such as ankylosing spondylitis; 
patients with juvenile idiopathic arthritis; and patients undergo-
ing hemiarthroplasty. 
Outcomes
The major variable assessed was prosthesis infection, defi ned 
as prosthesis malfunction, with pain and/or loss of joint 
function, beginning in the fi rst postoperative year and caus-
ing the exchange or removal of prosthetic components, and 
meeting one of the following criteria based on the Centers for 
Diseases Control (CDC) criteria:23 a) two or more cultures of 
bone biopsy or surgical material or synovial fl uid growing the 
same microorganism; b) purulent synovial fl uid seen by the 
surgeon; c) signs of infl ammation in the histopathological ex-
amination of the periprosthetic tissue; d) presence of cutaneous 
fi stula communicating directly with the prosthesis. 
Superfi cial incisional infection was identifi ed as the oc-
currence of superfi cial involvement of the surgical wound, in 
other words, of the skin and/or subcutaneous tissue, manifest-
ing within 30 days of the surgery, meeting one of three criteria 
based on the CDC and the Brazilian Health Surveillance 
Agency (ANVISA) criteria:24–27 a) superfi cial infl ammatory 
alterations of the surgical wound, in other words, skin and 
subcutaneous tissue (heat, redness, pain, edema, discharge), 
for which the assistant surgeon considered drainage and/or 
systemic antibiotic treatment necessary, except in case of nega-
tive culture; b) purulent discharge from the surgical wound; c) 
positive culture from tissue from the surgical wound. 
Deep incisional infection was identifi ed as the occurrence 
of deep involvement of the surgical wound, in other words, 
fascia or muscle, manifesting within the fi rst year of surgery 
and meeting one of the three criteria:24–26 a) purulent drainage 
from the deep incision, but not from the organ/cavity; b) partial 
or total dehiscence of the surgical scar or wound opening by the 
surgeon, if the patient had at least one of the following signs 
or symptoms: axillary temperature ≥ 37.8ºC, pain or increased 
local sensitivity, except in case of negative culture; presence of 
an abscess or other evidence that the infection involved deeper 
layers of the wound, identifi ed on reoperation, or clinical, histo/
cytopathological or imaging examinations.
Systemic infection was defi ned as the occurrence of an 
infection in any organ or system, for which oral or venous 
antibiotic therapy was indicated by the assistant team, with 
or without microbiological evidence, during hospitalization. 
Data collection
Data were collected from the electronic medical records of 
the SARAH network.  Patients with RA and OA undergoing 
hip or knee arthroplasties were selected through automatic 
search. The cases were counted according to the procedures 
performed. The following data were recorded: a) regarding the 
surgical procedures: surgical procedure performed; date of the 
fi rst arthroplasty; date of revision surgery or date of the last 
consultation or date of the patient’s death; infection documenta-
tion, including site, date, type of positive culture and causing 
germ, when available; American Society of Anesthesiology 
(ASA) physical status classifi cation and duration of surgery, 
which have been reported as factors related to prosthesis infec-
tion in at least three studies;15,27,28 b) data of RA patients: age, 
gender, educational level; disease-modifying antirheumatic 
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drugs (DMARDs) and/or corticosteroids used, with dose on 
the occasion of surgery; rheumatoid factor: positivity and 
measurement; c) data of OA patients: age, gender, educational 
level, OA etiology. 
Statistical analysis
Both descriptive and exploratory analyses of data were 
performed. Continuous variables were analyzed with mean 
comparison tests by use of analysis of variance (ANOVA). 
The qualitative variables were analyzed by use of Pearson’s 
chi-square test and/or Fisher’s exact test. Multiple logistic 
regression was used to exclude the infl uence of possible con-
founding variables. P values < 0.05 were considered statisti-
cally signifi cant. The software used for statistical analysis was 
SPSS® 13 for Windows. 
RESULTS
Case series
In the studied period, 160 surgeries were identifi ed in patients 
classifi ed as having RA. After excluding those that did not 
meet the above-mentioned criteria, 75 arthroplasties in patients 
with confi rmed RA were identifi ed as follows: 28 TKA and 
47 THA (Figure 1). The controls were randomly selected, 
according to case availability: 131 surgeries in OA patients 
(56 TKA and 75 THA).
All TKAs were performed by only one senior orthopedic 
surgeon, while the THAs were performed by two senior sur-
geons. All senior surgeons had a great experience with the 
procedures, and two of them have worked in the institution 
for over 30 years. 
General characteristics of the patients
The general data of the patients are summarized in Tables 
1 and 2. The signifi cant difference in the distribution of the 
ASA classifi cation may be explained by the fact that the 
presence of RA already increases the classifi cation to at least 
ASA 2. In the group of RA patients, rheumatoid factor was 
available in 65 patients, being positive in 73.2% of the THA 
group and in 87.5% of the TKA group. The mean rheumatoid 
factor titer was 266.97 (± 378.3) U/mL in the THA group and 
188.79 (± 164.1) U/mL in the TKA group. The DMARDs 
used by RA patients and their respective mean doses are 
shown in Table 3. 
Infections
The comparison of the incidence of infections is shown 
in Figures 2 and 3. Due to the small number of infections, 
Table 1
General characteristics of the patients of the THA group
THA group RA OA P
Gender (%) 0.276
Female 41 (87.2) 61 (81.3)
Male 8 (12.8) 14 (18.7)
Mean age (± SD) 50.6 (11.7) 63.46 (11.3) < 0.001
ASA (%) < 0.001
1 0 (0) 23 (30.7)
2 46 (97.9) 47 (62.7)
3 1 (2.1) 5 (6.7)
Mean surgical time 
in minutes (± SD)
142.09 (36.61) 136 (28.36) 0.307
Educational level 
(n = 113) (%)
0.001
Illiterate 1 (2.3) 3 (4.3)
Elementary School 16 (36.4) 48 (69.6)
High School 15 (34.1) 13 (18.8)
Higher Education 12 (27.3) 5 (7.2)
RA: rheumatoid arthritis; OA: osteoarthritis; ASA: American Society of Anesthesiology classifi cation 
of physical status.
Figure 1 
Selection of RA patients who underwent surgery. 
RA: rheumatoid arthritis; THA: total hip arthroplasty; TKA: total knee arthro-
plasty.
Automatic selection of RA patients x THA 
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Table 2
General characteristics of the patients of the TKA group
TKA group RA OA P
Gender (%) 0.46
Female 20 (71.4) 42 (75.0)
Male 8 (28.6) 14 (25.0)
Mean age (± SD) 54.91 (11.34) 70.97 (7.12) < 0.001
ASA (%) 0.200
1 0 (0) 6 (10.7)
2 27 (96.4) 48 (85.7)
3 1 (3.6) 2 (3.6)
Mean surgical time 
in minutes (± SD)
102.86 (39.62) 142.09 (25.84) 0.129
Educational level 
(n = 113) (%)
< 0.001
Illiterate 0 (0) 8 (17.0)
Elementary School 8 (34.8) 34 (72.3)
High School 12 (52.2) 4 (8.5)
Higher Education 3 (13.0) 1 (2.1)
RA: rheumatoid arthritis; OA: osteoarthritis; ASA: American Society of Anesthesiology classifi cation 
of physical status.
Table 3
DMARDs used by RA patients
THA TKA
DMARD (%) 37.0 (78.7) 24.0 (85.7)
MTX 28.0 (78.7) 16.0 (85.7)
LFN 9.0 (19.1) 5.0 (17.9)
SSZ 4.0 (8.5) 5.0 (17.9)
Antimalarial 13.0 (28.0) 7.0 (25.0)
Anti-TNF 1.0 (2.1) 2.0 (7.1)
Corticosteroid 30.0 (63.8) 18.0 (64.3)
Mean dose of DMARDs 
in mg (± SD)
MTX 10.7 (4.0) 9.3 (2.9)
LFN 20.0 (0.0) 20.0 (0.0)
SSZ 1000.0 (0.0) 1200.0 (273.9)
CQN 250.0 (0.0) 204.6 (65.6)
HCQN 200.0 (0.0) 400.0 (0.0)
Equivalent prednisone 6.9 (4.0) 10.2 (6.5)
THA: total hip arthroplasty; TKA: total knee arthroplasty; DMARD: disease-modifying 
antirheumatic drug; MTX: methotrexate; LFN: leflunomide; SSZ: sulfasalazine; CQN: chloroquine; 
HCQN: hydroxychloroquine.
Figure 2 
Incidence of prosthesis infections in the subsequent year of sur-
gery, incisional infections in the subsequent month of surgery, 
and systemic infections during hospitalization of the total hip 
arthroplasty group (fraction and percentage). 
RA: rheumatoid arthritis; OA: osteoarthritis.
Figure 3 
Incidence of prosthesis infections in the subsequent year of sur-
gery, incisional infections in the subsequent month of surgery, 
and systemic infections during hospitalization of the total knee 
arthroplasty group. 
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superfi cial and deep incisional infections were grouped as 
incisional infection. 
In the THA group, one RA patient presented prosthesis infec-
tion, but no OA patient did. In the TKA group, two RA patients 
had prosthesis infection, but no OA patient had it. In two cases, 
the infectious agent was the oxacillin-sensitive Staphylococcus 
aureus, and, in the third case, no culture was available. 
In the THA group, two RA patients and one OA patient 
had incisional infections. In the TKA group, four RA pa-
tients and two OA patients had incisional infections. No 
microbiological information on infection was available in 
any of those cases. 
Regarding systemic infections, in the THA group, two 
RA patients were identifi ed as follows: one upper airway 
infection and one cellulitis in the same operated-upon limb, 
but distant from the surgical site. Among OA patients, the 
following were identifi ed: two pneumonias; four urinary tract 
infections (UTI); one sepsis secondary to catheter infection; 
and one cellulitis. In the TKA group, among RA patients, the 
following were identifi ed: one sepsis secondary to septic ar-
thritis of the contralateral knee, caused by oxacillin-sensitive 
S. aureus; and one cellulitis. Among OA patients, two UTIs 
were identifi ed. In four cases of UTI, the etiologic agent was 
Escherichia coli, and no culture was available in the fi fth 
case. No germ was isolated in the pneumonia cases, and, in 
the catheter infection, Klebsiella pneumoniae was isolated 
from the blood culture.
In univariate analysis, no signifi cant difference was observed 
among the groups regarding the rates of prosthesis infection 
(both with P > 0.1), incisional infection (both with P > 0.1), and 
systemic infection (TKA, P = 0.92; and THA, P > 0.1).
Multiple logistic regression was carried out, including 
the following variables: gender; age; educational level; ASA 
classifi cation; and surgery duration. The stepwise backward 
automatic selection method was used with selection criterion 
P < 0.10. To assess the educational levels, the “illiterate” 
classifi cation was used as reference to compare with other 
educational levels. Regarding the ASA physical status classi-
fi cation, the “ASA 1” classifi cation was adopted as reference. 
Because of the reduced number of cases of infection observed, 
the variables “educational level” and “ASA physical status” 
had extreme coeffi cients and P values, with no statistical sig-
nifi cance. The other variables were also non-signifi cant in the 
adjusted model (P > 0.10), in other words, showed no signifi -
cant association in the groups regarding prosthesis, incisional 
and systemic infections.
DISCUSSION
Hip or knee arthroplasties in RA patients are relatively safe re-
garding the incidence of infections one year after the procedure, 
despite the use of corticosteroids and other immunomodulatory 
drugs, because no evidence of increased prosthesis, incisional 
and systemic infections was observed in this study. At fi rst, 
there is no reason not to provide such therapeutic modality 
for RA patients to relieve pain secondary to joint sequelae of 
the disease, which can be extremely severe.
The groups assessed differed regarding age, because RA 
patients are usually younger. In addition, there were signifi cant 
differences regarding the educational level of the patients, 
which may be explained by the progressive improvement in 
the socioeconomic status of the Brazilian population during 
the twentieth century. Such differences may have reduced 
the effect of the RA presence as a risk factor, in accordance 
with the fi ndings of two large retrospective studies that have 
reported  the low socioeconomic status as a risk factor for 
prosthesis infections.28,29 
In this study, it is worth emphasizing the quality of data 
collection, which was obtained from electronic medical 
records. In addition, well-defi ned criteria were used for 
diagnosing OA and RA, avoiding the inclusion of patients 
with other correlated diseases. To our knowledge, Brazilian 
studies that have comparatively evaluated the incidence of 
incisional and systemic infections in this context in a more 
specifi c way still lack.
Regarding the limitations of this study, we point out that 
our case series, although using all cases available, may not 
have been large enough to successfully demonstrate differences 
among the groups: the statistical power calculated post hoc was 
52% for the THA group, and 24% for the TKA group. One of 
the previously mentioned studies10 has shown a 0.4% difference 
in survival of TKA and no difference in survival of THA in fi ve 
years. This difference is very small and could only be evidenced 
because the study was multicenter and retrospective, assessing 
a whole country and including 108,786 surgeries. Analyzing 
the incidences of prosthesis and incisional infections in TKA, 
for instance, we observed a tendency towards a greater number 
of events in RA patients, but with no statistical signifi cance. 
On the other hand, the general rate of nosocomial infections in 
our hospital is very low, being 0.63% in 2010. This may have 
been a bias to determine differences among groups. Another 
point is that the control group was very heterogeneous, with 
OA patients of many etiologies, including some rare causes 
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secondary to systemic diseases, which may have different 
postoperative prognosis. 
In conclusion, RA was not identifi ed as a risk factor for 
perioperative infections in THA and TKA in this case series of 
the Hospital SARAH-Brasília as compared with the group of 
patients with primary OA or OA secondary to non-infl amma-
tory diseases. The low incidence of infections in both groups 
may explain our fi ndings. A Brazilian multicenter study could 
clarify the matter more defi nitively. 
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